Results 81 to 90 of about 9,262,118 (306)

Statistical Distributions for Damage Modelling: A Retrospect [PDF]

open access: yes
This paper reviews works on statistical damage modelling. Available literature shows that this method is flexible for modelling under-reporting and over-reporting of income, optimal replacement, accelerated test models, man-power analysis, rock ...
Lishamol Tomy   +2 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

A Systematic Review on the Evolution of Power Analysis Practices in Psychological Research

open access: yesPsychologica Belgica
Performing hypothesis tests with adequate statistical power is indispensable for psychological research. In response to several large-scale replication projects following the replication crisis, concerns about the root causes of this crisis – such as ...
Lara Vankelecom   +4 more
doaj   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Hypertension in pregnancy and statistical power [PDF]

open access: yesSao Paulo Medical Journal, 1996
Bothdrugshaveabout90percentefficacyinreducingblood pressure, butitisnotknown wichdrugcarriers lessriskofadverseeffectsforthefetus.Suppose thatonepercentoffetaldeathscouldbeattributed toonedrug,andtheotherdrugcould beattributed with0.5percent; thatmeans a50percent lesschance offetal deaths.
openaire   +4 more sources

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Virginia Tech's Laboratory for Interdisciplinary Statistical Analysis Annual Report 2015-16

open access: yes, 2016
This annual report summarizes the activities of LISA, Virginia Tech’s Laboratory for Interdisciplinary Statistical Analysis, during the fall and spring semesters of the 2015-16 academic year.
Vance, Eric A., Pruitt, Tonya
core  

Report on Statistical Disclosure Limitation Methodology [PDF]

open access: yes
Originally Prepared by Subcommittee on Disclosure Limitation Methodology 1994; Revised by Confidentiality and Data Access Committee 2005The Federal Committee on Statistical Methodology (FCSM) was organized by the Office of Management and Budget (OMB) in ...
United States. Federal Committee on Statistical Methodology
core   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy